Global Anti-Suicide Drugs Market Professional Survey Report 2019
Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.
The global Anti-Suicide Drugs market was valued at 3600 million US$ in 2018 and will reach 5210 million US$ by the end of 2025, growing at a CAGR of 4.7% during 2019-2025.
This report focuses on Anti-Suicide Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Suicide Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Suicide Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-Suicide Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
AstraZeneca plc
Eli Lilly and Company
Allergan plc
GlaxoSmithKline plc
Merck & Co., Inc
H. Lundbeck A/S
NeuroRx, Inc
Johnson & Johnson
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Anti-Depressants and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Segment by Application
Hospitals
Retail pharmacies
Online pharmacies
The global Anti-Suicide Drugs market was valued at 3600 million US$ in 2018 and will reach 5210 million US$ by the end of 2025, growing at a CAGR of 4.7% during 2019-2025.
This report focuses on Anti-Suicide Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Suicide Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Suicide Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-Suicide Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
AstraZeneca plc
Eli Lilly and Company
Allergan plc
GlaxoSmithKline plc
Merck & Co., Inc
H. Lundbeck A/S
NeuroRx, Inc
Johnson & Johnson
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Anti-Depressants and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Segment by Application
Hospitals
Retail pharmacies
Online pharmacies
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
